🇺🇸 FDA
Patent

US 7179894

Combinatorial selection of oligonucleotide aptamers

granted A61KA61K38/00

Quick answer

US patent 7179894 (Combinatorial selection of oligonucleotide aptamers) held by The Board of Regents of the University of Texas System expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00